NAGE

Niagen Bioscience
NAGE

Overview Fund Trends Analyst Outlook Journalist POV

55 hedge funds and large institutions have $17.7M invested in Niagen Bioscience in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

28% less call options, than puts

Call options by funds: $70K | Put options by funds: $97K

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$70K
Puts
$97K
Net Calls
Net Calls Change

Top Buyers

1
+$58.7K
2
+$52.3K
3
+$45.2K
4
Prudential Financial
Prudential Financial
New Jersey
+$40.5K
5
TCM
Tieton Capital Management
Washington
+$33.7K

Top Sellers

1
-$364K
2
-$167K
3
-$159K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$132K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$91.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$1K
52
$393
53
$262
54
$240
55
$43
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
1 2
3